3386.T Stock - Cosmo Bio Company,Limited
Unlock GoAI Insights for 3386.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $10.04B | $9.34B | $9.55B | $9.23B | $8.09B |
| Gross Profit | $3.33B | $3.25B | $3.44B | $3.66B | $3.15B |
| Gross Margin | 33.2% | 34.8% | 36.0% | 39.6% | 39.0% |
| Operating Income | $318.00M | $519.00M | $816.00M | $1.05B | $752.00M |
| Net Income | $262.00M | $442.00M | $517.00M | $737.00M | $674.00M |
| Net Margin | 2.6% | 4.7% | 5.4% | 8.0% | 8.3% |
| EPS | $45.05 | $75.83 | $89.13 | $126.94 | $113.70 |
Cosmo Bio Company,Limited engages in the import, export, manufacture, marketing, and sale of life science research biotools. Its life science research tools include reagents, kits, instruments, software, and diagnostics products. The company offers research reagents, such as antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, bacteria, and others, as well as offers detection reagents, cell and tissue culture systems, gene analysis systems, and others. It also provides research instruments comprising electrophoresis apparatuses, cell culture labware, gene manipulation systems, data analysis software, and others; drug discovery and custom research services; and clinical diagnostics. In addition, the company develops and manufactures cell/cell culture products, including adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem, and feeder cells, as well as tumor cell lines, coating reagents, macrophage-related products, etc.; and assay kit related products that comprise various measurement kits, staining kits, detection/purification kits, etc. Further, it offers biotechnology research equipment, which include constant-temperature transport containers, aluminum block mat heat insulation devices, dew condensation prevention glass plates, etc.; and consigned, custom peptide synthesis, and antibody production services. The company serves laboratories, research institutes, and life-science education and testing organizations. It sells its products through outlets in Japan, as well as a network of sales agents internationally. Cosmo Bio Company,Limited was founded in 1978 and is headquartered in Tokyo, Japan.
Visit WebsiteEarnings History & Surprises
3386.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 7, 2025 | — | $4.11 | — | — |
Q3 2025 | Aug 5, 2025 | — | $6.48 | — | — |
Q2 2025 | May 9, 2025 | — | $37.12 | — | — |
Q1 2025 | Feb 14, 2025 | — | $-5.04 | — | — |
Q4 2024 | Nov 7, 2024 | — | $5.66 | — | — |
Q3 2024 | Aug 5, 2024 | — | $4.79 | — | — |
Q2 2024 | May 9, 2024 | — | $39.42 | — | — |
Q1 2024 | Feb 14, 2024 | — | $13.02 | — | — |
Q4 2023 | Nov 7, 2023 | — | $0.86 | — | — |
Q3 2023 | Aug 4, 2023 | — | $16.58 | — | — |
Q2 2023 | May 10, 2023 | — | $45.58 | — | — |
Q1 2023 | Feb 14, 2023 | — | $10.85 | — | — |
Q4 2022 | Nov 7, 2022 | — | $8.08 | — | — |
Q3 2022 | Aug 4, 2022 | — | $7.06 | — | — |
Q2 2022 | May 10, 2022 | — | $63.19 | — | — |
Q1 2022 | Feb 14, 2022 | — | $21.06 | — | — |
Q4 2021 | Nov 5, 2021 | — | $21.58 | — | — |
Q3 2021 | Aug 5, 2021 | — | $27.13 | — | — |
Q2 2021 | May 10, 2021 | — | $56.78 | — | — |
Q1 2021 | Feb 12, 2021 | — | $16.70 | — | — |
Latest News
Frequently Asked Questions about 3386.T
What is 3386.T's current stock price?
What is the analyst price target for 3386.T?
What sector is Cosmo Bio Company,Limited in?
What is 3386.T's market cap?
Does 3386.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 3386.T for comparison